Just to advise those that visit this and the other

Just to advise those that visit this and the other board the company filed the required 10Q Friday 11/14/2025. Nothing very significant to report about but the following: "The decrease in operating expenses for the three months ended September 30, 2025 was primarily due to a decrease in consulting expenses of $158,521 as the Company terminated the services of certain consultants, and a decrease in research and development expenses of $40,551 as the Company purchased fewer external lab testing services, offset by an increase in legal services of $43,480 as the Company retained regulatory counsel to assist in correspondence with the FDA" FWIW hopefully counsel is in discussion with FDA regarding the IDE/PMA issue?

https://app.quotemedia.com/data/downloadFilin...11-14#P1I2